Your browser doesn't support javascript.
loading
Time to talk to adults with rheumatic diseases about herpes zoster vaccination.
Pier, Mischa; Wolbink, Gertjan; Boekel, Laura.
Affiliation
  • Pier M; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands.
  • Wolbink G; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Boekel L; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands. Electronic address: l.boekel@reade.nl.
Lancet Rheumatol ; 6(4): e247-e251, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38373432
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatic Diseases / Herpes Zoster Vaccine / Herpes Zoster Limits: Humans Language: En Journal: Lancet Rheumatol Year: 2024 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatic Diseases / Herpes Zoster Vaccine / Herpes Zoster Limits: Humans Language: En Journal: Lancet Rheumatol Year: 2024 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido